EDGAR Filing Documents for 0001193125-17-324222

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-17-324222

Filing Date

2017-10-30

Accepted

2017-10-30 10:43:41

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1/A	d445089ds1a.htm	S-1/A	1873890
2	EX-3.5	d445089dex35.htm	EX-3.5	11075
3	EX-5.1	d445089dex51.htm	EX-5.1	9839
4	EX-10.4	d445089dex104.htm	EX-10.4	64446
5	EX-10.11	d445089dex1011.htm	EX-10.11	7471
6	EX-10.15	d445089dex1015.htm	EX-10.15	33016
7	EX-23.1	d445089dex231.htm	EX-23.1	1516
8	GRAPHIC	g445089g22d56.jpg	GRAPHIC	25156
9	GRAPHIC	g445089g24u77.jpg	GRAPHIC	69805
10	GRAPHIC	g445089g27m37.jpg	GRAPHIC	50468
11	GRAPHIC	g445089g42k93.jpg	GRAPHIC	90215
12	GRAPHIC	g445089g51x82.jpg	GRAPHIC	127625
13	GRAPHIC	g445089g63g57.jpg	GRAPHIC	113711
14	GRAPHIC	g445089g67i47.jpg	GRAPHIC	75528
15	GRAPHIC	g445089g92h88.jpg	GRAPHIC	27889
16	GRAPHIC	g445089snap1.jpg	GRAPHIC	1535
	Complete submission text file	0001193125-17-324222.txt		2805158

Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014

Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114

Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)